Pasar al contenido principal

INTERVENCION TERAPEUTICA EN UN NUEVO MODELO EXPERIMENTAL DE ESTEATOHEPATITIS ALCOHOLICA Y NO-ALCOHOLICA (BASH): RELEVANCIA DEL EJE INTESTINO-HIGADO

PID2020-117827RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD COMPLUTENSE DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Tumor progression locus 2 (TPL2): A Cot-plicated progression from inflammation to chronic liver disease

  • Gutiérrez, Alejandro H.
  • Mazariegos, Marina
  • Alemany, Susana
  • Nevzorova, Yulia A.
  • Cubero, Francisco Javier
  • Sanz-García, Carlos
The cytoplasmic protein tumor progression locus 2 (TPL2), also known as cancer Osaka thyroid (Cot), or MAP3K8, is thought to have a significant role in a variety of cancers and illnesses and it is a key component in the activation pathway for the expression of inflammatory mediators. Despite the tight connection between inflammation and TPL2, its function has not been extensively studied in chronic liver disease (CLD), a major cause of morbidity and mortality worldwide. Here, we analyze more in detail the significance of TPL2 in CLD to shed light on the pathological and molecular transduction pattern of TPL2 during the progression of CLD. This might result in important advancements and enable progress in the diagnosis and treatment of CLD., This work has received funding from the MICINN Retos PID2020-113299RA-I00, PID2020-11782RB-I00, PID2020-117941RB-I00, PID2020-116146RB-I00 all of which were cofinanced with Fondos FEDER. The European Horizon's research and innovation programme HORIZON-HLTH-2022-STAYHLTH-02 under agreement No 101095679 and COST Action CA17112. CSG is an Atracción de Talento (CAM) Researcher 2019-T1/BMD-13313., Peer reviewed